July 16, 2024 02:25 PM EDT
Pharma
Law

Large group of state at­tor­neys gen­er­al backs Ore­gon drug price trans­paren­cy law

Nicole DeFeudis

Editor

In the lat­est chap­ter of years of le­gal back-and-forth, at­tor­neys gen­er­al from 20 states and the Dis­trict of Co­lum­bia have asked a fed­er­al ap­peals court …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Lykos CEO Amy Emer­son re­signs

FDA rais­es an­timi­cro­bial re­sis­tance con­cerns ahead of ad­comm for Iterum's UTI treat­ment

No­var­tis pays $15M up­front to li­cense Voy­ager pro­gram; Boehringer ad­vances ge­o­graph­ic at­ro­phy drug

Bio­Marin re­struc­tures fol­low­ing staff shake­up, slow Roc­ta­vian sales

Lil­ly un­veils more pos­i­tive late-stage da­ta for its once-week­ly in­sulin

sponsored

How to se­cure full en­roll­ment and a 30x ROI: A con­ver­sa­tion with the CEO of the bou­tique en­roll­ment agency do­ing just ...

A service from the Financial Times